Simulations Plus Inc
SLP
Detailliertes Diagramm anzeigen
17.130USD
-0.580-3.27%
Handelsschluss 11/07, 16:00（ET）Kurse um 15 Minuten verzögert
344.59MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
-3.27%
5 Tage
-0.29%
1 Monat
+3.82%
6 Monate
-40.91%
Seit Jahresbeginn
-38.58%
1 Jahr
-44.20%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von Simulations Plus Inc
Währung: USD Aktualisiert: 2025-11-07Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ gesund. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Das Unternehmen schneidet an der Börse gut ab, mit starken Fundamentaldaten und technischen Aspekten, die den aktuellen Trend unterstützen. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Simulations Plus Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
7
Analysten
Kaufen
Aktuelles Rating
23.000
Kursziel
+29.87%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Simulations Plus Inc Highlights
HöhepunkteRisiko
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
performance_growth_high
performance_growth_high_desc%!(EXTRA string=29.88%)
performance_growth_period
performance_growth_period_desc%!(EXTRA string=70.01M)
high_dividend
high_dividend_desc%!(EXTRA string=48.18%)
stable_dividend
stable_dividend_desc%!(EXTRA string=48.18%)
valuation_underestimated
valuation_underestimated_desc%!(EXTRA string=PE, string=-5.45)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=16.03M, string=14.22%)
institutional_hold%!(EXTRA string=ETHSX)
institutional_hold_desc%!(EXTRA string=ETHSX, string=119.00)
activity_decrease
activity_decrease_desc%!(EXTRA string=0.61)
Simulations Plus Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Simulations Plus Inc Informationen
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
BörsenkürzelSLP
UnternehmenSimulations Plus Inc
CEOMr. Shawn M. O'Connor
Websitehttps://www.simulations-plus.com/
Verwandte Finanzinstrumente
+0.82%
+1.13%
+1.14%
+2.23%
-0.35%
+0.98%
+0.63%
+2.38%
+1.11%
+0.42%
+1.06%
+3.20%
+0.13%
-0.74%
+0.25%
+1.15%
+1.25%
-0.51%
+0.74%
-0.40%Beliebte Symbole
